CEPI – Medical Alley Association

CEPI

Nucleus Network commences Novavax’ Phase 1/2 COVID-19 vaccine trial in Australia

Melbourne, Australia, Tuesday 26th May, Australia’s largest Phase 1 Clinical trials specialist, Nucleus Network, has today commenced dosing the first human participants for the Phase 1/2 trial of NVX‑CoV2373, a SARS-CoV-2 Recombinant Spike Protein Nanoparticle vaccine, at its Melbourne clinic. Nucleus Network has begun the Phase 1/2 COVID-19 vaccine trial in Australia on behalf of […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER